PTC Therapeutics Sees FY2026 Sales $700.000M-$800.000M vs $959.579M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
PTC Therapeutics (NASDAQ:PTCT) sees FY2026 sales of $700.000 million-$800.000 million vs $959.579 million analyst estimate.
PTC Therapeutics (NASDAQ:PTCT) sees FY2026 sales of $700.000 million-$800.000 million vs $959.579 million analyst estimate.